IPO registrations (S-1, F-1) · Registrants
Protea Biosciences Group, Inc.
- SEC CIK
- 1335103 · filings on EDGAR ↗
- Former names
- Protea Biosciences Inc. (2011–2011); SRKP 5 INC (2005–2011)
- Registration
- Form S-1, first filed 2014-01-13, last 2017-08-29; 4 initial registrations, 6 amendments
- Outcome
- Declared effective 2014-02-03; withdrawal requested 2016-08-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1311 PINEVIEW DRIVE, SUITE 501, Morgantown, WV 26505
- EDGAR entity type
- operating
- Insiders and CEO pay
- Protea Biosciences Group, Inc. on the corporate pages
On this site
- Form D issuer: Protea Biosciences Group, Inc. EXACT (CIK (EXACT))
- SEC filer: Protea Biosciences Group, Inc. EXACT (CIK (EXACT))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-01-13 | S-1 | S-1 (registration) | Protea Biosciences Group, Inc. | 0001144204-14-001891 ↗ |
| 2014-01-29 | S-1/A | S-1/A (amendment) | Protea Biosciences Group, Inc. | 0001144204-14-004717 ↗ |
| 2014-02-03 | EFFECT | EFFECT (declared effective) | Protea Biosciences Group, Inc. | 9999999995-14-000300 ↗ |
| 2014-12-31 | EFFECT | EFFECT (declared effective) | Protea Biosciences Group, Inc. | 9999999995-15-000005 ↗ |
| 2015-02-13 | S-1 | S-1 (registration) | Protea Biosciences Group, Inc. | 0001144204-15-009195 ↗ |
| 2015-04-16 | S-1/A | S-1/A (amendment) | Protea Biosciences Group, Inc. | 0001144204-15-023134 ↗ |
| 2015-04-17 | S-1/A | S-1/A (amendment) | Protea Biosciences Group, Inc. | 0001144204-15-023457 ↗ |
| 2015-04-21 | EFFECT | EFFECT (declared effective) | Protea Biosciences Group, Inc. | 9999999995-15-000939 ↗ |
| 2016-05-27 | S-1 | S-1 (registration) | Protea Biosciences Group, Inc. | 0001144204-16-105381 ↗ |
| 2016-06-22 | S-1/A | S-1/A (amendment) | Protea Biosciences Group, Inc. | 0001144204-16-109327 ↗ |
| 2016-07-14 | S-1/A | S-1/A (amendment) | Protea Biosciences Group, Inc. | 0001144204-16-113029 ↗ |
| 2016-07-15 | S-1/A | S-1/A (amendment) | Protea Biosciences Group, Inc. | 0001144204-16-113032 ↗ |
| 2016-08-26 | RW | RW (withdrawal request) | Protea Biosciences Group, Inc. | 0001144204-16-121378 ↗ |
| 2017-08-29 | S-1 | S-1 (registration) | Protea Biosciences Group, Inc. | 0001144204-17-045611 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| SCHWARTZBERG DEBBIE | Other; TenPercentOwner | 4 | 2006–2011 | ||
| PINTSOPOULOS ANTHONY C | Director,Officer,TenPercentOwner; Other | Secretary and CFO | 2 | 2007–2011 | |
| RAPPAPORT RICHARD | Director,Officer,TenPercentOwner; Other | President | 2 | 2007–2011 | |
| WestPark Capital Financial Services LLC | Other; TenPercentOwner | 2 | 2007–2011 | ||
| FRISCO CHARLES | TenPercentOwner | 1 | 2007 | ||
| ANTOLINE STEVE | Director; Director,TenPercentOwner | 16 | 2011–2017 | ||
| CLARK TOM | Director | 1 | 2011 | ||
| FLYNN DANIEL CHARLES | Director | 1 | 2011 | ||
| HARRIS LEONARD P | Director | 10 | 2011–2017 | ||
| HOSTLER STANLEY | Director; Director,Officer,TenPercentOwner | Secretary; Vice President and Secretary | 10 | 2011–2017 | |
| HUGHES EDWARD JOSEPH | Officer | Chief Financial Officer | 3 | 2011–2014 | |
| POWELL MATTHEW | Officer | Dir. R&D; Chief Science Off.; See Remarks | 4 | 2011–2014 | |
| PUSKAR MILAN | Director,TenPercentOwner | 1 | 2011 | ||
| ROBERSON ED | Director | 5 | 2011–2017 | ||
| SEGAL SCOTT | Director | 7 | 2011–2017 | ||
| TURNER STEPHEN C | Director,Officer | CEO and Chairman of the Board; Chief Executive Officer; See Remarks | 6 | 2011–2016 | |
| JACKSON ROD | Director | 3 | 2011–2014 | ||
| BALDI ALESSANDRO | Officer | See Remarks; VP; General Manager | 3 | 2011–2014 | |
| AUSTIN JOSIAH T | Director,TenPercentOwner; TenPercentOwner | 20 | 2012–2016 | ||
| El Coronado Holdings, LLC | Director,TenPercentOwner; TenPercentOwner | 19 | 2012–2014 | ||
| Spoor Johan M. | Director | 3 | 2013–2014 | ||
| KILBY GREG | Officer; OfficerOther | Chief Bioanalytics Officer; Vice President, Operations | 3 | 2014–2016 | |
| O'Loughlin Steve | Officer | VP, Corp Finance & Development | 1 | 2014 | |
| Shenouda Maged | Director | 2 | 2016 | ||
| Gallagher Patrick Joseph | Director | 2 | 2016 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-11-17 | Protea Biosciences Group, Inc. | Biotechnology | $5,000,000 | $631,680 | 25 | 1 |
| 2016-06-06 | Protea Biosciences Group, Inc. | Biotechnology | $2,500,000 | $691,000 | 14 | 1 |
| 2015-09-11 | Protea Biosciences Group, Inc. | Biotechnology | $4,000,000 | $452,500 | 8 | 1 |
| 2015-06-05 | Protea Biosciences Group, Inc. | Biotechnology | $2,000,000 | $2,000,000 | 1 | 1 |
| 2014-11-14 | Protea Biosciences Group, Inc. | Biotechnology | $12,000,000 | $4,426,528 | 57 | 1 |
| 2014-04-17 | Protea Biosciences Group, Inc. | Biotechnology | $1,100,000 | $175,000 | 1 | 1 |
| 2014-04-17 | Protea Biosciences Group, Inc. | Biotechnology | $900,000 | $600,000 | 1 | 1 |
| 2012-01-10 | Protea Biosciences Group, Inc. | Biotechnology | $10,000,000 | $280,000 | 10 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.